Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

The young biotech, sprung out of a Versant incubator in Switzerland, has a pair of antibody drugs it claims to have the ...

A new study published in Nature by researchers at Harvard Medical School has found that psychedelic compounds can reduce ...

These events are associated with innate training and can have long-term impacts on hematopoietic stem and progenitor cell (HSPC) development but can also compromise their function. While many ...

The following is a summary of “Treatment of plaque psoriasis with guselkumab reduces systemic inflammatory burden as measured by neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and ...

Gout, a prevalent form of inflammatory arthritis, is often linked to increased monocyte levels and decreased high-density ...

The following is a summary of "Association of eosinophil-to-monocyte ratio with asthma exacerbations in adults: a ...

Chronic lymphocytic leukemia (CLL) cell–derived exosomes demonstrated the ability to alter healthy donor cell function and ...

Merida Biosciences has emerged from Third Rock Ventures with $121 million in first-round financing for a pipeline of drugs ...

In a recent study in mice, we found that simply perceiving hunger can change the number of immune cells in the blood, even ...

Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...